Drug Profile
Asp-B25
Latest Information Update: 26 Feb 2001
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Developer Nonindustrial source
- Class Amino acids; Antihyperglycaemics; Insulins
- Mechanism of Action Phosphokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus